{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:27:46Z","timestamp":1789676866460,"version":"4.0.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"vor","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM120553"],"award-info":[{"award-number":["R01GM120553"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006151","name":"Basic Energy Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-AC02-05CH11231"],"award-info":[{"award-number":["DE-AC02-05CH11231"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","award":["UWPR95794"],"award-info":[{"award-number":["UWPR95794"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010296","name":"James B. Pendleton Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201700059C"],"award-info":[{"award-number":["HHSN272201700059C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018432","name":"California NanoSystems Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018432","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["1S10OD018111"],"award-info":[{"award-number":["1S10OD018111"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["1S10RR23057"],"award-info":[{"award-number":["1S10RR23057"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["1U24GM116792"],"award-info":[{"award-number":["1U24GM116792"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["ALTF 933-2015"],"award-info":[{"award-number":["ALTF 933-2015"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DBI-1338135"],"award-info":[{"award-number":["DBI-1338135"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["019.2015.2.310.006"],"award-info":[{"award-number":["019.2015.2.310.006"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.immuni.2018.03.026","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T11:38:59Z","timestamp":1523965139000},"page":"799-811.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus"],"prefix":"10.1016","volume":"48","author":[{"given":"Joost","family":"Snijder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Ortego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Weidle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Pancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Veesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2018.03.026_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2018.03.026_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nsmb.3115","article-title":"Privateer: software for the conformational validation of carbohydrate structures","volume":"22","author":"Agirre","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib3","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1073\/pnas.0810530106","article-title":"Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B","volume":"106","author":"Backovic","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/jvi.61.4.1125-1135.1987","article-title":"Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus","volume":"61","author":"Balachandran","year":"1987","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib5","article-title":"Byonic: advanced peptide and protein identification software","volume":"Chapter 13","author":"Bern","year":"2012","journal-title":"Current protocols in bioinformatics"},{"key":"10.1016\/j.immuni.2018.03.026_bib6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0602-594","article-title":"Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus","volume":"8","author":"Borza","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2018.03.026_bib7","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1128\/JVI.78.10.5007-5014.2004","article-title":"Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection","volume":"78","author":"Borza","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1107\/S1399004714021683","article-title":"Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions","volume":"71","author":"Brown","year":"2015","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2018.03.026_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1126\/sciimmunol.aan1457","article-title":"Structural basis for potent antibody-mediated neutralization of human cytomegalovirus","volume":"2","author":"Chandramouli","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2018.03.026_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2018.03.026_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/mBio.00290-11","article-title":"The KGD motif of Epstein-Barr virus gH\/gL is bifunctional, orchestrating infection of B\u00a0cells and epithelial cells","volume":"3","author":"Chen","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.immuni.2018.03.026_bib12","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1128\/JVI.03245-12","article-title":"The large groove found in the gH\/gL structure is an important functional domain for Epstein-Barr virus fusion","volume":"87","author":"Chen","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ultramic.2013.06.004","article-title":"High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy","volume":"135","author":"Chen","year":"2013","journal-title":"Ultramicroscopy"},{"key":"10.1016\/j.immuni.2018.03.026_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","article-title":"Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus","volume":"3","author":"Chen","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2018.03.026_bib15","doi-asserted-by":"crossref","first-page":"13214","DOI":"10.1128\/JVI.05580-11","article-title":"Fusion of Epstein-Barr virus with epithelial cells can be triggered by \u03b1v\u03b25 in addition to \u03b1v\u03b26 and \u03b1v\u03b28, and integrin binding triggers a conformational change in glycoproteins gHgL","volume":"85","author":"Chesnokova","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib16","doi-asserted-by":"crossref","first-page":"20464","DOI":"10.1073\/pnas.0907508106","article-title":"Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8","volume":"106","author":"Chesnokova","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nsmb.1837","article-title":"Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL","volume":"17","author":"Chowdary","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib18","doi-asserted-by":"crossref","first-page":"e1005230","DOI":"10.1371\/journal.ppat.1005230","article-title":"Antigenic characterization of the HCMV gH\/gL\/gO and pentamer cell entry complexes reveals binding sites for potently neutralizing human antibodies","volume":"11","author":"Ciferri","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.03.026_bib19","doi-asserted-by":"crossref","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"Suppl 2","key":"10.1016\/j.immuni.2018.03.026_bib20","doi-asserted-by":"crossref","first-page":"B194","DOI":"10.1016\/j.vaccine.2012.09.041","article-title":"The need and challenges for development of an Epstein-Barr virus vaccine","volume":"31","author":"Cohen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2018.03.026_bib21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","year":"1994","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2018.03.026_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrmicro2548","article-title":"Fusing structure and function: a structural view of the herpesvirus entry machinery","volume":"9","author":"Connolly","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.immuni.2018.03.026_bib23","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1016\/j.vaccine.2016.06.021","article-title":"Rabbits immunized with Epstein-Barr virus gH\/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350","volume":"34","author":"Cui","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2018.03.026_bib24","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"},{"key":"10.1016\/j.immuni.2018.03.026_bib25","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells","volume":"95","author":"Delecluse","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jmb.2009.07.008","article-title":"Refinement of protein structures into low-resolution density maps using rosetta","volume":"392","author":"DiMaio","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.3286","article-title":"Atomic-accuracy models from 4.5-\u00c5 cryo-electron microscopy data with density-guided iterative local refinement","volume":"12","author":"DiMaio","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2018.03.026_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/JVI.01791-15","article-title":"New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency","volume":"90","author":"Doria-Rose","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib29","doi-asserted-by":"crossref","first-page":"e1006182","DOI":"10.1371\/journal.ppat.1006182","article-title":"Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial","volume":"13","author":"Easterhoff","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.03.026_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/jvi.39.1.172-184.1981","article-title":"Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences","volume":"39","author":"Edson","year":"1981","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2018.03.026_bib32","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/pr301130k","article-title":"Unambiguous phosphosite localization using electron-transfer\/higher-energy collision dissociation (EThcD)","volume":"12","author":"Frese","year":"2013","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.immuni.2018.03.026_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jsb.2006.06.010","article-title":"Visualizing density maps with UCSF Chimera","volume":"157","author":"Goddard","year":"2007","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib34","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1128\/JVI.74.5.2451-2454.2000","article-title":"Epstein-Barr\u00a0virus entry utilizing HLA-DP or HLA-DQ as a coreceptor","volume":"74","author":"Haan","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/viro.2001.1141","article-title":"Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virus-induced membrane fusion","volume":"290","author":"Haan","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2018.03.026_bib36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/505912","article-title":"A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in\u00a0vitro and in\u00a0vivo","volume":"194","author":"Haque","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.immuni.2018.03.026_bib37","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/JVI.02531-15","article-title":"Epstein-Barr virus gp350 can functionally replace the rhesus lymphocryptovirus major membrane glycoprotein and does not restrict infection of rhesus macaques","volume":"90","author":"Herrman","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib38","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.77.5.2979","article-title":"Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen","volume":"77","author":"Hoffman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib39","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/nprot.2013.117","article-title":"Isolation of human monoclonal antibodies from peripheral blood B cells","volume":"8","author":"Huang","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2018.03.026_bib40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2018.03.026_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7554\/eLife.18722","article-title":"Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2","volume":"5","author":"Kimanius","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2018.03.026_bib42","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.1128\/JVI.00572-06","article-title":"Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion","volume":"80","author":"Kirschner","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib43","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1128\/JVI.00575-07","article-title":"Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH\/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion","volume":"81","author":"Kirschner","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib44","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/356347a0","article-title":"Epstein-Barr virus infection and replication in a human epithelial cell system","volume":"356","author":"Li","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.03.026_bib46","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1128\/jvi.69.7.3987-3994.1995","article-title":"The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells","volume":"69","author":"Li","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib47","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib48","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1115941109","article-title":"Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention","volume":"109","author":"Magro","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib49","doi-asserted-by":"crossref","first-page":"22641","DOI":"10.1073\/pnas.1011806108","article-title":"Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H\/glycoprotein L (gH\/gL) complex","volume":"107","author":"Matsuura","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib50","doi-asserted-by":"crossref","first-page":"10618","DOI":"10.1038\/ncomms10618","article-title":"Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice","volume":"7","author":"McGuire","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2018.03.026_bib51","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.immuni.2018.03.026_bib52","first-page":"187","article-title":"Analysis of fusion using a virus-free cell fusion assay","volume":"292","author":"McShane","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib53","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1128\/jvi.66.6.3409-3414.1992","article-title":"Epstein-Barr virus enters B cells and epithelial cells by different routes","volume":"66","author":"Miller","year":"1992","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/125.4.403","article-title":"Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines","volume":"125","author":"Miller","year":"1972","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.immuni.2018.03.026_bib55","doi-asserted-by":"crossref","first-page":"13570","DOI":"10.1128\/JVI.02272-14","article-title":"The conserved disulfide bond within domain II of Epstein-Barr virus gH has divergent roles in membrane fusion with epithelial cells and B cells","volume":"88","author":"M\u00f6hl","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib56","doi-asserted-by":"crossref","first-page":"286","DOI":"10.14348\/molcells.2016.0066","article-title":"Structural and mechanistic insights into the tropism of Epstein-Barr virus","volume":"39","author":"M\u00f6hl","year":"2016","journal-title":"Mol. Cells"},{"key":"10.1016\/j.immuni.2018.03.026_bib57","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells","volume":"74","author":"Molesworth","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib58","doi-asserted-by":"crossref","first-page":"e25797","DOI":"10.1371\/journal.pone.0025797","article-title":"H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination","volume":"6","author":"Moody","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.immuni.2018.03.026_bib59","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1099\/0022-1317-17-2-233","article-title":"Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in\u00a0vitro","volume":"17","author":"Moss","year":"1972","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib60","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","article-title":"Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults","volume":"25","author":"Moutschen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2018.03.026_bib61","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1073\/pnas.232381299","article-title":"Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection","volume":"99","author":"Neuhierl","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.celrep.2013.01.023","article-title":"Human complement receptor type 1\/CD35 is an Epstein-Barr Virus receptor","volume":"3","author":"Ogembo","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2018.03.026_bib63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/viro.1998.9530","article-title":"Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay","volume":"254","author":"Okuma","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2018.03.026_bib64","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1128\/JVI.79.19.12408-12415.2005","article-title":"The amino terminus of Epstein-Barr virus glycoprotein gH is important for fusion with epithelial and B cells","volume":"79","author":"Omerovi\u0107","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.immuni.2018.03.026_bib66","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.immuni.2018.03.026_bib67","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1128\/JVI.00457-09","article-title":"Functional analysis of glycoprotein L (gL) from rhesus lymphocryptovirus in Epstein-Barr virus-mediated cell fusion indicates a direct role of gL in gB-induced membrane fusion","volume":"83","author":"Plate","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virol.2010.12.006","article-title":"Mapping regions of Epstein-Barr virus (EBV) glycoprotein B (gB) important for fusion function with gH\/gL","volume":"413","author":"Plate","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2018.03.026_bib69","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2018.03.026_bib70","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.it.2014.01.003","article-title":"Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory","volume":"35","author":"Rickinson","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2018.03.026_bib71","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jmb.2003.07.013","article-title":"Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy","volume":"333","author":"Rosenthal","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2009.06.013","article-title":"Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay","volume":"391","author":"Sashihara","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2018.03.026_bib73","doi-asserted-by":"crossref","first-page":"e1004309","DOI":"10.1371\/journal.ppat.1004309","article-title":"Assembly and architecture of the EBV B cell entry triggering complex","volume":"10","author":"Sathiyamoorthy","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.immuni.2018.03.026_bib74","doi-asserted-by":"crossref","first-page":"13557","DOI":"10.1038\/ncomms13557","article-title":"Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins","volume":"7","author":"Sathiyamoorthy","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2018.03.026_bib75","doi-asserted-by":"crossref","first-page":"E8703","DOI":"10.1073\/pnas.1704661114","article-title":"Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies","volume":"114","author":"Sathiyamoorthy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib76","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nmeth.2115","article-title":"Prevention of overfitting in cryo-EM structure determination","volume":"9","author":"Scheres","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2018.03.026_bib77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2017.02.008","article-title":"Vitrification after multiple rounds of sample application and blotting improves particle density on cryo-electron microscopy grids","volume":"198","author":"Snijder","year":"2017","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib78","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase\u00a02, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.immuni.2018.03.026_bib79","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1128\/jvi.70.8.5557-5563.1996","article-title":"The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation","volume":"70","author":"Spriggs","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coviro.2012.10.005","article-title":"Stuck in the middle: structural insights into the role of the gH\/gL heterodimer in herpesvirus entry","volume":"3","author":"Stampfer","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib81","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/jvi.41.1.258-264.1982","article-title":"Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen","volume":"41","author":"Strnad","year":"1982","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","article-title":"Automated molecular microscopy: the new Leginon system","volume":"151","author":"Suloway","year":"2005","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib83","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","article-title":"EMAN2: an extensible image processing suite for electron microscopy","volume":"157","author":"Tang","year":"2007","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20161846","article-title":"Human immunity against EBV-lessons from the clinic","volume":"214","author":"Tangye","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2018.03.026_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(87)90216-9","article-title":"Epstein-Barr virus gp350\/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis","volume":"50","author":"Tanner","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2018.03.026_bib86","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.20112272","article-title":"Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen","volume":"209","author":"Taylor","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2018.03.026_bib87","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2018.03.026_bib88","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1073\/pnas.77.9.5307","article-title":"Monoclonal antibodies against the major glycoprotein (gp350\/220) of Epstein-Barr virus neutralize infectivity","volume":"77","author":"Thorley-Lawson","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib89","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm830","article-title":"Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells","volume":"9","author":"Tugizov","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2018.03.026_bib90","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1128\/JVI.00622-06","article-title":"Antibodies to gp350\/220 enhance the ability of Epstein-Barr virus to infect epithelial cells","volume":"80","author":"Turk","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib91","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jsb.2009.01.004","article-title":"DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy","volume":"166","author":"Voss","year":"2009","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib92","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1128\/JVI.72.7.5552-5558.1998","article-title":"Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells","volume":"72","author":"Wang","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib93","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2018.03.026_bib94","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1128\/JVI.79.17.10923-10930.2005","article-title":"Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells","volume":"79","author":"Wu","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2018.03.026_bib95","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.1501176112","article-title":"A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL","volume":"112","author":"Xing","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2018.03.026_bib96","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2018.03.026_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","article-title":"Gctf: Real-time CTF determination and correction","volume":"193","author":"Zhang","year":"2016","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2018.03.026_bib98","first-page":"164","article-title":"Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2018.03.026_bib99","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat. Methods"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761318301249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761318301249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:03:09Z","timestamp":1761033789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761318301249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1074761318301249"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2018.03.026","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2018.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}